Cassava Sciences, Inc. (SAVA)
2.29
-0.06
(-2.55%)
USD |
NASDAQ |
Feb 27, 13:27
Cassava Sciences Research and Development Expense (Quarterly) : 3.955M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| cbdMD, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Amicus Therapeutics, Inc. | 23.74M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Ovid Therapeutics, Inc. | 5.853M |